Professor| University of New York | United States
Dr. Probal Banerjee is a distinguished Professor of Chemistry and Coordinator of the Center for Developmental Neuroscience at The College of Staten Island, City University of New York, renowned for his pioneering contributions at the intersection of chemistry, neuroscience, and molecular pharmacology. Holding a Ph.D. in Bioorganic Chemistry from the Indian Institute of Science, Bangalore, and postdoctoral training at the University of Notre Dame and the University of Chicago, he has produced over 100 peer-reviewed publications that have advanced understanding of serotonergic signaling in brain development and innovative therapeutic strategies in cancer biology. His groundbreaking research on the 5-HT1A receptor’s role in neonatal hippocampal neurogenesis and on curcumin-based multi-target cancer therapies has redefined approaches to neurodevelopmental and oncological disorders, emphasizing immune modulation and translational impact. Dr. Banerjee’s recent studies on immune-friendly prodrugs and synergistic natural compounds reflect his commitment to safe, mechanism-driven, and sustainable therapeutic innovation. A frequent invited speaker at global scientific forums including Columbia University, NASA Ames, and the Indian Institute of Science, he collaborates internationally to bridge fundamental discovery with clinical relevance. Recognized with multiple honors such as the Brain Research Foundation Award and two Dolphin Awards for academic excellence and teaching, Dr. Banerjee continues to mentor emerging scientists and shape global biomedical research through his visionary work integrating molecular neuroscience, immunology, and drug development to enhance human health worldwide
Featured Publications
Salutary effects of transdermal curcumin on multiple indices of health span in rodent models of normal aging and hypertension. Geroscience. 1 citation (2025).
Targeting sickle cell pathobiology and pain with novel transdermal curcumin. PNAS Nexus. 2 citations (2025).
Corrigendum: Dietary polyphenols, resveratrol and pterostilbene exhibit antitumor activity on an HPV E6-positive cervical cancer model: an in vitro and in vivo analysis. Frontiers in Oncology. 2 citations (2019).
Biocompatible anisole-nonlinear PEG core–shell nanogels for high loading capacity, excellent stability, and controlled release of curcumin. Gels. 8 citations (2023).
Why don’t the mutant cells that evade DNA repair cause cancer more frequently? Importance of the innate immune system in the tumor microenvironment. International Journal of Molecular Sciences. 4 citations (2023).
The G protein-coupled serotonin 1A receptor augments protein kinase Cε-mediated neurogenesis in neonatal mouse hippocampus—PKCε-mediated signaling in the early hippocampus. International Journal of Molecular Sciences. 2 citations (2022).
Dr. Probal Banerjee’s research bridges chemistry, neuroscience, and immunology to pioneer multi-target therapeutic strategies that combat cancer and neurodevelopmental disorders. His innovative work on curcumin-based immune therapies and serotonergic signaling mechanisms has advanced translational medicine, inspiring new, safer, and globally accessible approaches to human health and disease management.
